LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H (HK:2291) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. successfully passed several key resolutions at its Extraordinary General Meeting, held on December 10, 2024. The meeting approved the Entrusted Products Related Framework Agreement with overwhelming shareholder support, with over 99.99% of votes in favor. The resolutions set the stage for the company’s strategic transactions and operational plans through 2027.
For further insights into HK:2291 stock, check out TipRanks’ Stock Analysis page.